Exploratory Study to Inventory Opportunities to Optimize Continuity of Pharmacotherapy at Hospital Discharge
NCT ID: NCT03223584
Last Updated: 2018-02-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2015-11-30
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Exploratory study to inventory opportunities to optimize continuity of pharmacotherapy at hospital discharge
Study area:
Care region Leuven (individual interviews), care region Bruges (individual interviews) and care region Mortsel (One focus group).
Aims:
From an explorative angle, the study aims to identify hurdles, barriers, facilitators and needs that general practitioners and community pharmacists experience with patients who have recently been discharged from a hospital. From a feasibility standpoint, the study aims to investigate what supportive actions are feasible and useful to optimize the care process upon hospital discharge. For this purpose, a discharge document for the community pharmacist will be shown to the healthcare professionals. The HCP will be given the opportunity to give feedback on this document.
Study design:
A non-interventional, qualitative study is set up using face-to-face, semi-structured interviews and a focus group.
Study population:
Community pharmacists and general practitioners that are employed in the study region and that are considered opinion leaders.
Number of health care professionals:
Individual interviews will be organised until there is saturation of information and no new elements are provided in the interviews. At least five community pharmacists and five general practitioners will be interviewed per care region. In addition, a focus group will take place in care region Mortsel.
Procedures:
Upon an informed consent of the healthcare professional, a semi-structured face-to-face interview will take place. The interview will focus on concrete patient cases, provided by the healthcare professional, as well as a fictional case of the researcher. In the focus group, data of the individual interviews will be presented and the relevance and completeness of the information will be assessed. Finally, the aim of the focus group is to reach a consensus on the research questions.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Studying the Impact of a Medication Use Evaluation by the Community Pharmacist
NCT03179722
Evaluation of the Effectiveness of a Continuing Education Program in Community Pharmacies
NCT03388567
Deprescribing in a Long Term Care Facility
NCT03091153
Trial of a Pharmacist-physician Intervention Model to Reduce High-risk Drug Use by Hospitalised Elderly Patients
NCT02570945
OPTImization of Medication by Transdisciplinary Assessment of Drug Treatment in Elderly Hospitalized Patients
NCT05387096
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pharmacists-Leuven
Individual interviews with approximately 5 pharmacists
No interventions assigned to this group
Pharmacists-Bruges
Individual interviews with approximately 5 pharmacists
No interventions assigned to this group
Pharmacists-Mortsel
A focus group with pharmacists and general practitioners
No interventions assigned to this group
General Practitioners-Leuven
Individual interviews with approximately 5 general practitioners
No interventions assigned to this group
General Practitioners-Bruges
Individual interviews with approximately 5 general practitioners
No interventions assigned to this group
General Practitioners-Mortsel
A focus group with pharmacists and general practitioners
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Employment in care regions Leuven, Bruges or Kontich
* Experience in daily practice
* Interest in research or optimisation of the healthcare profession. For example supervisors of an internship, local coordinators of general practitioners or pharmacy clusters and active HCP that are linked with professional associations.
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joke Wuyts
PharmD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
KU Leuven
Leuven, Vlaams-Brabant, Belgium
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wuyts J, Vande Ginste M, De Lepeleire J, Foulon V. Discharge report for the community pharmacist: Development and validation of a prototype. Res Social Adm Pharm. 2020 Feb;16(2):168-177. doi: 10.1016/j.sapharm.2019.04.049. Epub 2019 Apr 25.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S58480
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.